The role of the linker between the SH2 domain and catalytic domain in the regulation and function of Src

被引:130
|
作者
Gonfloni, S [1 ]
Williams, JC [1 ]
Hattula, K [1 ]
Weijland, A [1 ]
Wierenga, RK [1 ]
Superti-Furga, G [1 ]
机构
[1] European Mol Biol Lab, D-69117 Heidelberg, Germany
关键词
Lck; protein kinase; regulation; Src; structure;
D O I
10.1093/emboj/16.24.7261
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The crystal structures of the regulated Src and Hck tyrosine kinases show intramolecular interactions between the phosphorylated tail and the SH2 domain as well as between the SH3 domain, the SH2-catalytic domain linker (SH2-CD linker) and the catalytic domain, The relative contribution of these interactions to regulation of activity is poorly understood. Mutational analysis of Src and Lck revealed that interaction of the SH2-CD linker with the SH3 domain is crucial for regulation, Moreover, three sites of interaction of the linker with the catalytic domain, one at the beginning (Trp260) and two at the back of the small lobe, opposite the catalytic cleft (beta 2/beta 3 loop; alpha C/beta 4 loop), impinge on Src activity, Other activating mutations map to the front of the catalytic domain in the loop preceding the alpha C-helix (beta 3/alpha C loop), SH2-CD linker mutants are deregulated in mammalian cells but transform fibroblasts weakly, suggesting that the linker may bind cellular components. Interpretation of our results on the basis of the crystal structure of Src favours a model in which the correctly positioned SH2-CD linker exerts an inhibitory function on catalysis of Src family members by facilitating displacement of the alpha C-helix, This study may provide a template for the generation of deregulated versions of other protein kinases.
引用
收藏
页码:7261 / 7271
页数:11
相关论文
共 50 条
  • [21] The distinct capacity of Fyn and Lck to phosphorylate Sam68 in T cells is essentially governed by SH3/SH2-catalytic domain linker interactions
    Feuillet, V
    Semichon, M
    Restouin, A
    Harriague, J
    Janzen, J
    Magee, A
    Collette, Y
    Bismuth, G
    ONCOGENE, 2002, 21 (47) : 7205 - 7213
  • [22] The role of the Src homology-2 domain in the lethal effect of Src expression in the yeast Saccharomyces cerevisiae
    Trager, JB
    Martin, GS
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1997, 29 (04) : 635 - 648
  • [23] Sensitive Approaches for the Assay of the Global Protein Tyrosine Phosphorylation in Complex Samples Using a Mutated SH2 Domain
    Li, Yanan
    Wang, Yan
    Dong, Mingming
    Zou, Hanfa
    Ye, Minghang
    ANALYTICAL CHEMISTRY, 2017, 89 (04) : 2304 - 2311
  • [24] Thermodynamics of phosphotyrosine peptide-peptoid hybrids binding to the p56Ick SH2 domain
    Dekker, F. J.
    de Mol, N. J.
    Liskamp, R. M. J.
    JOURNAL OF PEPTIDE SCIENCE, 2010, 16 (07) : 322 - 328
  • [25] The effector functions of mature T lymphocytes are impaired in transgenic mice expressing the SH2 domain of TSAd/Lad
    Choi, Youngbong
    Park, Eunkyung
    Ahn, Eunseon
    Park, Inyoung
    Yun, Yungdae
    MOLECULES AND CELLS, 2009, 28 (03) : 183 - 188
  • [26] A Src SH2 selective binding compound inhibits osteoclast-mediated resorption
    Violette, SM
    Shakespeare, WC
    Bartlett, C
    Guan, W
    Smith, JA
    Rickles, RJ
    Bohacek, RS
    Holt, DA
    Baron, R
    Sawyer, TK
    CHEMISTRY & BIOLOGY, 2000, 7 (03): : 225 - 235
  • [27] BINDING IN-VITRO OF PHOSPHOTYROSINE-CONTAINING PROTEINS TO PP60(C-SRC) SH2 DOMAIN DOES NOT CORRELATE WITH CEF CELL-TRANSFORMATION
    BOEUF, H
    MURPHY, J
    BIBBINS, KB
    VARMUS, HE
    ONCOGENE, 1995, 10 (03) : 433 - 438
  • [28] Bone-targeted Src SH2 inhibitors block Src cellular activity and osteoclast-mediated resorption
    Violette, SM
    Guan, W
    Bartlett, C
    Smith, JA
    Bardelay, C
    Antoine, E
    Rickles, RJ
    Mandine, E
    Van Schravendijk, MR
    Adams, SE
    Lynch, BA
    Shakespeare, WC
    Yang, M
    Jacobsen, VA
    Takeuchi, CS
    Macek, KJ
    Bohacek, RS
    Dalgarno, DC
    Weigele, M
    Lesuisse, D
    Sawyer, TK
    Baron, R
    BONE, 2001, 28 (01) : 54 - 64
  • [29] Backbone assignment of the tyrosine kinase Src catalytic domain in complex with imatinib
    Ramón Campos-Olivas
    Marco Marenchino
    Leonardo Scapozza
    Francesco L. Gervasio
    Biomolecular NMR Assignments, 2011, 5 : 221 - 224
  • [30] Backbone assignment of the tyrosine kinase Src catalytic domain in complex with imatinib
    Campos-Olivas, Ramon
    Marenchino, Marco
    Scapozza, Leonardo
    Gervasio, Francesco L.
    BIOMOLECULAR NMR ASSIGNMENTS, 2011, 5 (02) : 221 - 224